Lindus

Lindus is a next-generation CRO with accountability built in, engineered to give biotech and pharmaceutical sponsors confidence and control to generate clinical data on time and on budget. In the last 3 years, Lindus has executed over 45 full-scope trials across cardiometabolic, respiratory, psychiatry, dermatology, women's health, and diagnostics. Behind each study is an integrated operating model spanning feasibility, central enrollment infrastructure, and flexible site models. Trials run on Citrus™, an AI-native trial operating system, and are governed by performance-based contracts with milestone-based payments. 82% of Lindus executed trials completed enrollment on or ahead of our proposed timeline. The company is backed by Dr. Bob Langer, Peter Thiel, and Dr. Tim Garnett.